IOL Chemicals

IOLCP04 Mar 2024
Pharmaceuticals
-6.10 (-1.49%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in IOL Chemicals
IOL Chemicals
Pharmaceuticals
IOLCP04 Mar 2024
-6.10 (-1.49%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

IOL Chemicals - Share Price & Details

Lowest Today
402
Highest Today
416.3
Today’s Open
416.3
Prev. Close
409.1
52 Week High
535.6
52 Week Low
272.2
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
40.61%
Upper Circuit
Lower Circuit
P/E TTM
13.92
P/B Ratio
1.51
Traded Value(Cr)
0.00
EPS TTM
29.38
Book value
Dividend
0.98%

Price Performance

-2.19 %
1 Wk
-7.72 %
1 M
-10.29 %
3 M
40.61 %
1 Y
-13.84 %
YTD

Traded Volume Movement

Technical Details

Support 3
393
Support 2
398
Support 1
401
Pivot Point :
406
Resistance 1
409
Resistance 2
414
Resistance 3
416

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
403.00-6.102,401.6440.6113.921.51
Cipla Ltd
₹1,487.65(+4.55/0.31%)
1,487.65+4.55119,739.4963.4336.414.63
Astrazeneca Pharma India Ltd
₹5,410.00(-29.40/-0.54%)
5,410.00-29.4013,598.5061.7485.2620.76
Bliss GVS Pharma Ltd
₹124.80(-1.10/-0.87%)
124.80-1.101,318.0659.0819.311.35
Abbott India Ltd
₹28,191.20(+111.80/0.40%)
28,191.20+111.8059,668.7340.6652.0919.19
Amrutanjan Health Care Ltd
₹664.35(-5.00/-0.75%)
664.35-5.001,956.556.8144.457.47

About IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals & Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 2401.64 crores. It has reported a sales of Rs. 520.39 crores and a net profit of Rs. 23.23 crores for the quarter ended December 2018. The company management includes Rajender Mohan Malla, Varinder Gupta,Sandhya Mehta,Vikas Gupta,Rajender Mohan Malla,Harpal Singh,Abhay Raj Singh,Kushal Kumar Rana,SHARAD TYAGI,Abhiraj Gupta (IOL Chemicals & Pharmaceuticals Ltd) among others.
Chairman
Rajender Mohan Malla
Registered office
Trident Complex,Raikot Road  Barnala,Sangrur,Punjab,148101
FAX :91-01679-244708
Background
Incorporation Year1986
Face Value₹10
Market Lot1

Latest News

Large caps likely to outperform broader market: Analysts
The Indian market is poised to maintain its positive momentum, with large-cap stocks expected to outperform the broader market. This trend is indicated by the Nifty vs Nifty 500 ratio reaching its lowest point. Analysts anticipate Nifty to climb towards 22,800, provided it remains above 22,300. Some of the recommended stocks include Reliance Industries, Axis Bank, ICICI Bank, SBI, Infosys.
04 Mar 2024 | 10:05 AM
Chartist Talks | What makes Rohit Srivastava of India charts bullish?
After the Nifty 50 hit a new record high last week, the trendline indicated a new resistance near 22,360. The index needs to trade above this level for a few days to prove that the breakout from consolidation was sustainable, according to Rohit Srivastava, founder of Strike Money Analytics and India charts. The veteran with nearly three decades spent in the equity markets.
04 Mar 2024 | 09:53 AM
Stocks To Watch: ZEE, JIO Financials, Paytm, Axis Bank, Asian Paints!
GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a positive opening on Monday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: GIFT Nifty traded up by 60.50 points or 0.27% at 22,511 indicating a positive opening for domestic indices NSE Nifty 50 and BSE Sensex on Monday.
04 Mar 2024 | 09:32 AM
📢 Benchmark indices open on a flat note today; Nifty near 22,402.
📈 Amid mixed global cues, benchmark indices started on a flat note today. 📊 At 9:16 AM, the Sensex gained 96.94 points or 0.13% at 73,903.09 and the Nifty was up 25.10 points or 0.11% at 22,401.50. 📢NTPC (⬆️2.19%), and Nifty Energy (⬆️0.67%) appeared as the top performers on the Nifty50 at open. Tata Steel and JSW Steel are in focus today.
04 Mar 2024 | 09:21 AM
These pharma and healthcare microcap multibaggers turned MF favourites!
After putting up a tepid performance in 2022, pharma and healthcare funds made a strong comeback over the last 15 months with the Nifty Pharma index significantly outperforming the Nifty 50. Experts attribute this to a stable pricing environment in the US. So far this year, the pharmaceutical funds category yielded 10 percent returns, while the Nifty 50 index gained only 1 percent.
04 Mar 2024 | 09:14 AM
Click here to see your activities